In the George-SCLC cohort, there were more B cells, CD4+ T cells, M1 macrophages, NK cells, and myeloid dendritic cells in the TGFB-HIGH group than in the TGFB-LOW group (all p < 0.05, Figure 5(b)). This evidence concerns the gene TGFB1 and small cell lung carcinoma.